Through our private venture capital funds, we invest in promising companies with technological advantages in sustainable chemistry, cleantech, health-tech, digital technologies and artificial intelligence. We are convinced that by investing in new technologies and innovations we can make a positive impact on our society and contribute to a better and more sustainable world, whilst achieving an acceptable return.
We support the growth of our portfolio companies as active value adding shareholders towards successful businesses and profitable exits.
Rob van der Meij, Partner at Capricorn Partners sat down with Kathryn Sheridan from Sustainability Consult to share his insider perspective from the world of biotech financing. Read the full article here.
New agreement with Trillium Renewable Chemicals will enable Solvay's development of sustainable, bio-carbon fiber for use in various applications. Brussels, Belgium : 12 January 2022 – Solvay and Trillium Renewable Chemicals have signed a letter of…